Form 4: Cytek Biosciences Executive Yan Ming Reports Stock Option and Restricted Stock Unit Awards

Cytek Biosciences' Chief Technology Officer, Yan Ming, reports the acquisition of stock options and restricted stock units.

Summary

• On March 6, 2024, Yan Ming, Chief Technology Officer of Cytek Biosciences, Inc., reported the acquisition of employee stock options and restricted stock units (RSUs).
• The stock options grant Yan Ming the right to buy 131,578 shares of Cytek's common stock at an exercise price of $7.07 per share.
• These options vest over four years, starting April 6, 2024, with 1/48th of the total shares vesting monthly thereafter.
• Yan Ming also acquired 88,401 restricted stock units, each representing a contingent right to receive one share of Cytek's common stock.
• These RSUs vest over four years, with varying portions vesting on specific dates in May, August, November, and March each year.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options and RSUs is a standard practice and generally viewed as a positive incentive for executives.

Positives

• The granting of stock options and RSUs to a key executive like the CTO suggests an incentive to align their interests with the company's long-term success.
• The vesting schedules encourage continued service and contribution to Cytek Biosciences over the next four years.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Stock options and RSUs are common forms of compensation for executives in the biotechnology industry, aligning their interests with shareholder value and company performance.

Comparison to Industry Standards

• Stock option and RSU grants are standard practice in the biotech industry for executive compensation.
• Companies like Illumina, Thermo Fisher Scientific, and Danaher also utilize similar equity-based compensation plans to incentivize their leadership teams.
• The vesting schedules (monthly and quarterly) are also typical, encouraging long-term commitment.

Stakeholder Impact

• The stock options and RSUs granted to Yan Ming could potentially impact shareholders by diluting the value of existing shares if the options are exercised.
• Employees may view this as a positive sign, indicating the company's commitment to incentivizing its leadership.

Key Dates